Survival after segmentectomy and wedge resection in stage i non-small-cell lung cancer

Journal of Thoracic Oncology

Volumn 8, Issue 1, 2013, Pages 73-78

  Smith, Cardinale B ^a,b   Swanson, Scott J ^c   Mhango, Grace ^b   Wisnivesky, Juan P ^b  

^a Tisch Cancer Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Limited resection; Non small cell lung cancer; Segmentectomy; Survival; Wedge resection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEGMENTECTOMY; WEDGE RESECTION;

EID: 84871959073     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31827451c4     Document Type: Article

References (33)

1. Spiro SG, Porter JC. Lung cancer-where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002;166:1166-1196.
2. Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995;60:466-472.
3. Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-76.
4. Harpole DH Jr, Herndon JE II, Young WG Jr, Wolfe WG, Sabiston DC Jr. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-796.
5. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
6. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22.
7. Wisnivesky J P, Henschke CI, Swanson S, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 2010;251: 550-554.
8. Kates M, Swanson S, Wisnivesky J P. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung can-cer<=1 cm in size: a review of SEER data. Chest 2011;139:491-496.
9. Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001;71:956-60; discussion 961.
10. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003;125:924-928.
11. Watanabe T, Okada A, Imakiire T, Koike T, Hirono T. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn J Thorac Cardiovasc Surg 2005;53:29-35.
12. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-775.
13. Bilfnger T V, Baram D. Sublobar resection in nonsmall cell lung carcinoma. Curr Opin Pulm Med 2008;14:292-296.
14. Sienel W, Dango S, Kirschbaum A, et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in signifcantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg 2008;33:728-734.
15. Available at: http://www.seer.cancer.gov. Accessed December 2009.
16. Fritz A, Percy C, Jack, A. International Classifcation of Diseases for Oncology. Geneva, Switzerland: World Health Organization, 2000.
17. Wei LJ, Lin DY, Weissfeld L. Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal Distributions. J Am Stat Assoc 1989;84:1065-1073.
18. Ludwig MS, Goodman M, Miller DL, Johnstone PA. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 2005;128:1545-1550.
19. Yoshino I, Nakanishi R, Osaki T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest 1999;116:144-149.
20. Demir A, Turna A, Kocaturk C, et al. Prognostic signifcance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Ann Thorac Surg 2009;87:1014-1022.
21. Warren WH, Faber L P. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994;107:1087-93.
22. Sienel W, Stremmel C, Kirschbaum A, et al. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is infuenced by segment localisation and width of resection margins-implications for patient selection for segmentectomy. Eur J Cardiothorac Surg 2007;31:522-527.
23. Wisnivesky J P, Yankelevitz D, Henschke CI. The effect of tumor size on curability of stage I non-small cell lung cancers. Chest 2004;126:761-765.
24. Rusch V W, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P; Members of IASLC Staging Committee. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classifcation for lung cancer. J Thorac Oncol 2009;4:568-577.
25. Blanchard EM, Arnaoutakis K, Hesketh PJ. Lung cancer in octogenarians. J Thorac Oncol 2010;5:909-916.
26. Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128:237-245.
27. Palma DA, Tyldesley S, Sheehan F, et al. Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment? J Thorac Oncol 2010;5:818-824.
28. Available at: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview= abst-detail-view&confID=17&abstractID=16068. Accessed January 12, 2012.
29. Lund JL, Harlan LC, Yabroff KR, Warren JL. Should cause of death from the death certifcate be used to examine cancer-specifc survival? A study of patients with distant stage disease. Cancer Invest 2010;28:758-764.
30. Hoffman RM, Stone SN, Hunt WC, Key CR, Gilliland FD. Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol 2003;13:450-454.
31. Doria-Rose V P, Marcus PM. Death certifcates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. Lung Cancer 2009;63: 295-300.
32. Dautzenberg B, Arriagada R, Chammard AB, et al. A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 1999;86:265-273.
33. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998;352:257-263.